Allied Market Research

2025

Pharmsource - Bio/pharma Capex Market

PharmSource - Bio/Pharma CapEx Market, by Therapeutic Area (Oncology, Neurology, Cardiovascular, Infectious Diseases, Endocrinology, Immunology), by Duration of Clinical Trials (Early Phase, Late Phase), by Average Cost of RD (High, Medium, Low) and, by Regulatory Approval (FDA, European Medicines Agency, Japan's Pharmaceuticals and Medical Devices Agency): Opportunity Analysis and Industry Forecast, 2023-2032

LS : Other

Select an option
Author's: | Roshan Deshmukh
Publish Date: